Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature

BACKGROUND: For advanced lung squamous cell carcinoma, immune checkpoint inhibitors (ICIs) have been regarded as one of the optimal therapies. While immune-related adverse events (irAEs) are common in ICI treatment, cutaneous toxicities are among the most common irAEs. Most immune-related skin toxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jing-Yi, Kang, Kai, Yi, Jing, Yang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254208/
https://www.ncbi.nlm.nih.gov/pubmed/35949835
http://dx.doi.org/10.12998/wjcc.v10.i18.6110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254208/
https://www.ncbi.nlm.nih.gov/pubmed/35949835
http://dx.doi.org/10.12998/wjcc.v10.i18.6110

Ejemplares similares